Charles Farkas Conmed Corp (CNMD) insider trading activity

Charles Farkas is Director of CONMED Corp. Currently has a direct ownership of 16,380 shares of CNMD, which is worth approximately $929,565. The most recent transaction as insider was on May 29, 2025, when has been sold 966 shares (Common Stock) at a price of $57.69 per share, resulting in proceeds of $55,728. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.4K

19.49% 3M change

17.61% 12M change

Total Value Held $929,565

Charles Farkas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 29 2025	SELL Payment of exercise price or tax liability	$55,728 $57.69 p/Share	966 Reduced 5.57%	16,380 Common Stock
May 29 2025	BUY Exercise of conversion of derivative security	$55,700 $55.7 p/Share	1,000 Added 5.45%	17,346 Common Stock
May 05 2025	SELL Open market or private sale	$227,760 $56.94 p/Share	4,000 Reduced 19.66%	16,346 Common Stock
Sep 05 2024	SELL Payment of exercise price or tax liability	$39,681 $74.31 p/Share	534 Reduced 2.56%	20,346 Common Stock
Sep 05 2024	BUY Exercise of conversion of derivative security	$39,640 $39.64 p/Share	1,000 Added 4.57%	20,880 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	302 Added 1.5%	19,880 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	335 Added 1.68%	19,578 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	812 Added 4.05%	19,243 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	1,521 Added 7.62%	18,431 Common Stock

Charles Farkas

Director

Largo, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNMD shares.

Notify only if

Value

Insider Trading

Get notified when an Conmed Corp insider buys or sells CNMD shares.

Notify only if

Operation

Value

Type

News

Receive news related to CONMED Corp

Track Activities on CNMD

Account